Saturday, November 6, 2010

Hawaii firm

http://travel365.us/3dworldatlas.html
Researchers and clinicians at have spent the past 18 months developintg the technology for an advanced imaging device that will more efficiently screen women forcervical cancer, the second most common cancer in STI Medical Systems is a division of , which primarilgy develops life sciences technology and medicakl diagnostic systems. Its latest product, the , is an advanced magnifyin g device that allows gynecologists to more thoroughlt examine patients whose initial screening tests comeback abnormal. It allows doctors to take high-resolutionn images that can be uploaded directly intoa patient’s electroni medical record, which ultimately results in more efficient follow-up exams.
The slim unit sits on a waist-highb chassis outfitted with a high-resolution camera and touch-screen computer system that is no more than sixinche wide, said Will Alameida, senior vice presiden of Science & Technology International. Historically, the procedurs was done with relatively bulky equipmeng that producedgrainy images. Or doctors would have to draw picturesafrom memory. Simply put, it streamlines to two steps a procedur e that used to takeseven steps. “Thiz space of women’s health hasn’t changed in 50 to 60 years,” said Rolf senior vice president of STIMedicalp Systems.
“Our instrument is highly integrated, ergonomically designed and streamlines the clinicalo work flow by making it very easy for the doctorr to conductthe exam.” The systemn already is being used by the at sitexs in Spokane, Wash., and Anchorage, Alaska. And clinicak studies have been done atin Honolulu, Eisenhower Medical Center in California and Walter Reed Army Medica l Center in Washington, D.C.
Private hospitals in Hawaii includingtThe Queen’s Medical Center and also are in talkes to test the Wolters said the company recently introduced the unit at threew medical technology trade shows in Europe where it generatedc “tremendous interest” and landed a deal to placee the devices at two London hospitals withi the next month. The systemn was developed with private funding and support fromthe U.S. Army’s Telemedicinde and Advanced TechnologyResearch Center. STI is collaborating with a Mainlands medical-device manufacturer to build more units.
Demandc for them is expected to rise givehnthe 11,270 new cervical cancer cases in the Uniteds States and 493,000 new cases worldwide every Established in 1996, Science & Technology International was a well-knownm defense contractor when it sold its government systems division to BAE Systems North America for $27 millioj in 2004 to focus on life It also owns PanThera BioPharma, an Aiea pharmaceuticalp company currently developing a pill-form treatment for anthrax.

No comments:

Post a Comment